|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.32 USD | -1.71% |
|
-2.64% | -30.03% |
| 06-02 | Daxor Says Received US Patent for Remote Blood Volume Monitor Technology | MT |
| 04-26 | 5,061,267 Common Stock of Daxor Corporation are subject to a Lock-Up Agreement Ending on 27-APR-2026. | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | ||
| 4.177 | +11.83% | 3 | ||||||
| 1.5 | +10.95% | 2 | ||||||
| 11.5 | +14.54% | 10 | ||||||
| Average | 5.73 | +12.44% | 5 | ||||||
| Weighted average by Cap. | 5.27 | +12.27% | 5 |
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Sector Daxor Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
